Tag: therapies

Technology for Social Good

FintechJanuary 27, 2024

In a world where Technology has become deeply ingrained in our lives, its ability to bring about change and contribute to the betterment of...

A Child Born Deaf Can Hear for the First Time Thanks to Pioneering Gene Therapy

AIJanuary 25, 2024

When Aissam Dam had the strange device connected to his ear, he had no idea it was going to change his life.An 11-year-old boy,...

Focused ultrasound plus plaque-reducing drugs could slow Alzheimer’s progression – Physics World

QuantumJanuary 24, 2024

<a href="https://coingenius.news/wp-content/uploads/2024/01/focused-ultrasound-plus-plaque-reducing-drugs-could-slow-alzheimers-progression-physics-world-3.jpg" data-fancybox data-src="https://coingenius.news/wp-content/uploads/2024/01/focused-ultrasound-plus-plaque-reducing-drugs-could-slow-alzheimers-progression-physics-world-3.jpg" data-caption="Deliver the drugs Researchers at the West Virginia University Rockefeller Neuroscience Institute, shown in the MRI...

Caution required: anaesthesia with supplemental oxygen can impact proton therapy – Physics World

QuantumJanuary 22, 2024

<a href="https://coingenius.news/wp-content/uploads/2024/01/caution-required-anaesthesia-with-supplemental-oxygen-can-impact-proton-therapy-physics-world-2.jpg" data-fancybox data-src="https://coingenius.news/wp-content/uploads/2024/01/caution-required-anaesthesia-with-supplemental-oxygen-can-impact-proton-therapy-physics-world-2.jpg" data-caption="Protecting the brain A preclinical study has demonstrated the need to optimize anaesthesia and supplemental oxygen...

Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling

BlockchainJanuary 17, 2024

GENEVE, CH, Jan 17, 2024 - (ACN Newswire) - With cancer projected to escalate to 29 million cases by 2040, Novigenix, a pioneer in...

Psychedelics Rapidly Fight Depression—a New Study Offers a First Hint at Why

AIJanuary 16, 2024

Depression is like waking up to a rainy, dreary morning, every single day. Activities that previously lightened the mood lose their joy. Instead, every...

Xcellerant Ventures Ends First Year with 10th Investment, Leading CRISPR QC’s $10 Million Series A Round

FintechJanuary 6, 2024

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#CRISPR–Xcellerant Ventures is proud to announce its investment in CRISPR QC, the San Diego-based biotechnology company that has developed the world’s first...

U.S. Food and Drug Administration Approves ZELSUVMI™ as a First-in-Class Medication for the Treatment of Molluscum Contagiosum

FintechJanuary 5, 2024

ZELSUVMI™ is expected to be commercially available during the second half of 2024 SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S....